Women's Health
Fertility, maternal health, pelvic and breast health devices. 15 companies listed.
Developing Amber-UI, an adaptive neuromodulation implant that senses as well as stimulates, for mixed urinary incontinence in women. Spun out of Oxford University research.
Makes a portable cryoablation device that lets nurses and community health workers treat precancerous cervical cells at the point of care in primary care clinics.
Makes LapBox, a bag-in-bag tissue containment system for laparoscopic morcellation. Both the manual and the power versions are FDA cleared.
Developing Maternal aRMOR, a wrist worn monitor that uses laser and camera sensing of red blood cell flow to detect postpartum hemorrhage. Won the MedTech Innovator 2025 grand prize.
Sells devices for office-based gynecology, including the HERizon Vista hysteroscopy platform and the Symphion tissue removal system. It distributes Porter Instrument's Nitronox Plus nitrous oxide system to US gynecology practices.
Makes a condensing device that turns breast milk into a shelf-stable powder for hospital NICUs, removing frozen storage and defrosting from the nursing workflow.
Sells Clairity Breast, FDA-authorized software that estimates a woman's five-year breast cancer risk from an existing screening mammogram. Now also offered directly to patients through Everlywell.
Develops the Claria System, a contained tissue removal device for minimally invasive hysterectomy, funded by NSF and NIH grants.
Makes a compact automated scanner that captures a 3D ultrasound volume of the breast in about a minute, with machine learning applied to flag abnormal masses.
Remote prenatal and postpartum monitoring. The M•care System uses the M•wrap wearable and abdominal electrodes to capture fetal and maternal heart rate at home and send it to clinicians.
Developing a device that stabilizes and closes the cervix to retain amniotic fluid and extend pregnancy in women at risk of preterm birth.
Makes the Prapela SVS bassinet pad, which delivers randomized vibration to treat neonatal opioid withdrawal syndrome. Technology licensed from Harvard's Wyss Institute.
Pulsenmore makes a smartphone cradle that lets pregnant women perform ultrasound scans at home for remote reading by clinicians. It is listed on the Tel Aviv Stock Exchange.
Sells the Teal Wand, an FDA-authorized self-collection device for at-home HPV cervical cancer screening, with samples run by a partner lab.
Womed makes a resorbable polymer film that is placed in the uterus after hysteroscopic surgery to prevent adhesions. It also works on intrauterine drug delivery for fibroids and endometriosis.
New clearances, funding rounds and regulatory moves for device founders, and every new how-to guide and template as it lands. No noise, no login.
You're in. The next morning brief lands in your inbox.